1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Edesa Biotech Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19 SOC plus 15mg/kg EB05 IV, SOC plus Placebo IV - COVID-19, ARDS | Phase 2 / Phase 3 | Terminated | Edesa Biotech Inc. | 278 | 2020-11-25 | 2026-10-28 |
COVID-19 (1)
Canada (1) · United States (1)